“STUDY OF PULMONARY HYPERTENSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE”
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 7, Pages 7185-7193
AbstractBackground: Pulmonary hypertension is a recognised complication of chronic kidney disease, especially in end stage renal disease. It has prevalence estimates of 30-50%. Present study aimed to study magnitude of pulmonary artery hypertension in chronic kidney disease patients
Material & Method: This observational analytical cross sectional study was conducted among the adult more than 18yrs of age with CKD attending department of general medicine. After obtaining informed and written consent from the patients, detailed history, clinical assessment and laboratory diagnosis to be done. (Blood urea, Serum creatinine, Serum uric acid, Serum electrolytes, Urine Routine, Complete hemogram, Liver function tests)
Result: The mean age of the patients was found to be 49.45±8.97yrs, with majority of the patients in age group of 41-60yrs. On gender assessment majority of the patients were male (68%), with male preponderance. There is 18.4% of patients presented with pulmonary hypetension. There is a significant higher incidence of the pulmonary hypertension among the patients with stage 3 (30.4%) and stage 4 CKD (60.9%) patients.
Conclusion: CKD patients have a higher prevalence of pulmonary hypertension. The prevalence of pulmonary hypertension is high in stage 5 CKD patients, and it is also higher in dialysis patients. In CKD patients, there is no gender difference in the development of pulmonary hypertension.
- Article View: 28
- PDF Download: 15